Year: 2008
Type: article
Study design: Case Report
Abstract: Osteonecrosis of the Jaw Related to BevacizumabA 51-year-old female with history of infiltrating ductal carcinoma of the right breast was diagnosed in late 2001 and treated with mastectomy in February 2002.She was subsequently treated with adjuvant chemotherapy with doxorubicin and cyclophosphamide for four cycles followed by hormonal therapy with letrozole for three years.She was diagnosed with a chest wall recurrence, involving the soft tissues in the right axillary and supra-clavicular areas in early 2006 and underwent six cycles of chemotherapy with albumin-bound nanoparticle-paclitaxel.She subsequently underwent a chest wall resection in September 2006, followed by radiation to the chest wall.She started capecitabine at the dose of 1000 mg twice a day, two weeks on and one week off, in October 2006 (in concurrence with radiation therapy to the chest wall).In December 2006, the dose of capecitabine was increased to 1500 mg AM and 1000 mg PM, also two weeks on and one week off.Bevacizumab was also started in late December 2006 at the dose of 15 mg/kg for 3 weeks for a total of 8 doses, the last one in May 2007.Six weeks following the last dose of bevacizumab, the patient presented with a 2-month history of complaints of lower jaw discomfort and what the she described as protruding bone in the lower jaw.The patient denied any recent history of dental or oral surgery.Examination revealed a small area of bone exposure in the left posterior lingual mandible, measuring approximately 1 ϫ 1 mm in diameter.The bone appeared necrotic.The surrounding soft tissue appeared normal with no evidence of infection.The rest of the oral and dental examination was unremarkable.The exposed bone was smoothed with a bone file.The patient was prescribed chlorhexidine 0.12% oral rinse.Bevacizumab and capecitabine were discontinued.A few weeks later, the area of exposed bone had resolved.The overlying mucosa appeared normal.However, there was now a new area of 1 ϫ 1 mm exposed bone in the right posterior lingual mandible (Fig 1A).The bone was mobile and was easily removed.Histological examination of the bony specimen (Fig 1B) showed devitalized, necrotic bone (NB, black arrowhead) demonstrating a scalloped, "moth-eaten" appearance.Bacterial colonies occupied those areas in which there was loss of mineralized bone.
Source: Journal of Clinical Oncology
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Topic: Bone health and treatments
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2122429800
